Marijuana Use In Pregnant Women with Disabilities in the United States

Overview

Journal Matern Child Health J

Specialty Health Services

Date 2022 Jan 4

PMID 34982342

Citations 2

Authors

Panagiota Kitsantas

Salman M Aljoudi

Gilbert Gimm

Affiliations

Soon will be listed here.

Abstract

Objectives: While perinatal marijuana use is increasing, limited research exists related to its use during pregnancy among vulnerable subpopulations of women with disabilities. The purpose of this study is to assess marijuana use in pregnant U.S. women with disabilities.

Methods: The analytic sample using 2015-2019 National Survey on Drug Use and Health (NSDUH) data included 3657 pregnant women. Descriptive statistics were performed and adjusted logistic regression models estimated the size and direction of the association between the type of disability and marijuana use.

Results: Approximately 13.0% of pregnant women with disabilities used marijuana in the past month, which was higher than pregnant women without disabilities (4.4%). The highest prevalence of past month marijuana use was observed among pregnant women with sensory disabilities (17.2%) followed by women with cognitive disabilities (14.6%) and daily living limitations (11.7%). Marijuana use was also associated with younger age (≤ 25 years old), Black non-Hispanic, high school education or less, non-married, and past month alcohol/tobacco use. Overall, pregnant women with any disability, and particularly those with sensory disabilities (AOR 2.32, 95% CI 1.21, 4.47), were significantly more likely (AOR 1.65, 95% CI 1.02, 2.69) to use marijuana than their counterparts without disabilities.

Conclusions: The higher prevalence of marijuana use among pregnant women with disabilities in this study supports the American College of Obstetricians and Gynecologists recommendations for universal screening of maternal substance use. Screening for marijuana use in vulnerable populations is crucial and it may require training of health care providers to administer such screenings to women with disabilities.

Citing Articles

Prenatal Exposure to Cannabis: Effects on Childhood Obesity and Cardiometabolic Health.

Moore B Curr Obes Rep. 2024; 13(1):154-166.

PMID: 38172481 PMC: 10933144. DOI: 10.1007/s13679-023-00544-x.

Emerging Roles of Endocannabinoids as Key Lipid Mediators for a Successful Pregnancy.

Rava A, Trezza V Int J Mol Sci. 2023; 24(6).

PMID: 36982295 PMC: 10048990. DOI: 10.3390/ijms24065220.

References

Brown Q, Sarvet A, Shmulewitz D, Martins S, Wall M, Hasin D . Trends in Marijuana Use Among Pregnant and Nonpregnant Reproductive-Aged Women, 2002-2014. JAMA. 2016; 317(2):207-209. PMC: 5595220. DOI: 10.1001/jama.2016.17383. View

Chen C, Storr C, Anthony J . Early-onset drug use and risk for drug dependence problems. Addict Behav. 2008; 34(3):319-22. PMC: 2677076. DOI: 10.1016/j.addbeh.2008.10.021. View

Conner S, Bedell V, Lipsey K, Macones G, Cahill A, Tuuli M . Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysis. Obstet Gynecol. 2016; 128(4):713-723. DOI: 10.1097/AOG.0000000000001649. View

Corsi D, Donelle J, Sucha E, Hawken S, Hsu H, El-Chaar D . Maternal cannabis use in pregnancy and child neurodevelopmental outcomes. Nat Med. 2020; 26(10):1536-1540. DOI: 10.1038/s41591-020-1002-5. View

Crume T, Juhl A, Brooks-Russell A, Hall K, Wymore E, Borgelt L . Cannabis Use During the Perinatal Period in a State With Legalized Recreational and Medical Marijuana: The Association Between Maternal Characteristics, Breastfeeding Patterns, and Neonatal Outcomes. J Pediatr. 2018; 197:90-96. DOI: 10.1016/j.jpeds.2018.02.005. View

Dickson B, Mansfield C, Guiahi M, Allshouse A, Borgelt L, Sheeder J . Recommendations From Cannabis Dispensaries About First-Trimester Cannabis Use. Obstet Gynecol. 2018; 131(6):1031-1038. PMC: 5970054. DOI: 10.1097/AOG.0000000000002619. View

Glazier R, Kling R . Recent trends in substance abuse among persons with disabilities compared to that of persons without disabilities. Disabil Health J. 2013; 6(2):107-15. DOI: 10.1016/j.dhjo.2013.01.007. View

Grzeskowiak L, Grieger J, Andraweera P, Knight E, Leemaqz S, Poston L . The deleterious effects of cannabis during pregnancy on neonatal outcomes. Med J Aust. 2020; 212(11):519-524. DOI: 10.5694/mja2.50624. View

Guille C, Aujla R . Developmental Consequences of Prenatal Substance Use in Children and Adolescents. J Child Adolesc Psychopharmacol. 2019; 29(7):479-486. DOI: 10.1089/cap.2018.0177. View

10.

Hayatbakhsh M, Flenady V, Gibbons K, Kingsbury A, Hurrion E, Mamun A . Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res. 2012; 71(2):215-9. DOI: 10.1038/pr.2011.25. View

11.

Iezzoni L, Yu J, Wint A, Smeltzer S, Ecker J . General health, health conditions, and current pregnancy among U.S. women with and without chronic physical disabilities. Disabil Health J. 2014; 7(2):181-8. PMC: 3971389. DOI: 10.1016/j.dhjo.2013.12.002. View

12.

Ko J, Coy K, Haight S, Haegerich T, Williams L, Cox S . Characteristics of Marijuana Use During Pregnancy - Eight States, Pregnancy Risk Assessment Monitoring System, 2017. MMWR Morb Mortal Wkly Rep. 2020; 69(32):1058-1063. PMC: 7440118. DOI: 10.15585/mmwr.mm6932a2. View

13.

Ko J, Tong V, Bombard J, Hayes D, Davy J, Perham-Hester K . Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: A population-based study. Drug Alcohol Depend. 2018; 187:72-78. PMC: 7479809. DOI: 10.1016/j.drugalcdep.2018.02.017. View

14.

Mitra M, Clements K, Zhang J, Iezzoni L, Smeltzer S, Long-Bellil L . Maternal Characteristics, Pregnancy Complications, and Adverse Birth Outcomes Among Women With Disabilities. Med Care. 2015; 53(12):1027-32. PMC: 4648667. DOI: 10.1097/MLR.0000000000000427. View

15.

Mitra M, Parish S, Clements K, Cui X, Diop H . Pregnancy outcomes among women with intellectual and developmental disabilities. Am J Prev Med. 2014; 48(3):300-8. DOI: 10.1016/j.amepre.2014.09.032. View

16.

Passey M, Sanson-Fisher R, DEste C, Stirling J . Tobacco, alcohol and cannabis use during pregnancy: clustering of risks. Drug Alcohol Depend. 2013; 134:44-50. DOI: 10.1016/j.drugalcdep.2013.09.008. View

17.

Ryan S, Ammerman S, OConnor M . Marijuana Use During Pregnancy and Breastfeeding: Implications for Neonatal and Childhood Outcomes. Pediatrics. 2018; 142(3). DOI: 10.1542/peds.2018-1889. View

18.

Stetten N, Pomeranz J, Moorhouse M, Yurasek A, Blue A . The level of evidence of medical marijuana use for treating disabilities: a scoping review. Disabil Rehabil. 2018; 42(9):1190-1201. DOI: 10.1080/09638288.2018.1523952. View

19.

van Gelder M, Reefhuis J, Caton A, Werler M, Druschel C, Roeleveld N . Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study. Drug Alcohol Depend. 2010; 109(1-3):243-7. DOI: 10.1016/j.drugalcdep.2010.01.007. View

20.

Vesga-Lopez O, Blanco C, Keyes K, Olfson M, Grant B, Hasin D . Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry. 2008; 65(7):805-15. PMC: 2669282. DOI: 10.1001/archpsyc.65.7.805. View